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Abstract
Objectives: The present study was aimed at advancing the understanding of the pathogenesis of cherubism by 
presenting a case study based on history, physical examination, typical radiological features, molecular and histo-
pathological laboratory tests and a review of the literature.
Study Design: This study began with a 7-year-old boy who was referred due to mandibular overgrowth. A pan-
oramic radiograph revealed multilocular radiolucent lesions of the upper/lower jaws suggestive of cherubism. 
Overall, a total of four family members were tested for SH3BP2 mutations, namely two siblings and their parents. 
Both siblings had been clinically diagnosed with cherubism; however, the parents were clinically normal. Periph-
eral blood was collected from all participants and genomic DNA sequencing was carried out.
Results: A missense mutation was found in the two affected siblings and their asymptomatic mother. The mu-
tation was a 1244 G>A transversion which resulted in an amino acid substitution from arginine to glutamine 
(p.Arg415Gln) in exon 9. 
Conclusions: The present study emphasized the importance of further clinical and molecular investigation even 
when only a single case of cherubism is identified within a family. Genotype-phenotype association studies in 
individuals with cherubism are necessary to provide important insights into the molecular mechanisms associated 
with this disease.
Key words: Cherubism, mandible, maxilla, SH3BP2, gene analysis, CBCT.  
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Introduction
Cherubism, which was first described by Jones (1) in 
1933, is a rare non-neoplastic and hereditary self-limit-
ing fibro-osseous disease with excessive bone resorption 
and multilocular lesions in the upper and/or lower jaws 
during childhood. Affected children are observed to be 
normal at birth and have normal mental development. 
Bone expansion becomes noticeable in early childhood 
and continues progressively until puberty, when the le-
sions usually resolve at the beginning of adolescence 
(2). The phenotype ranges from asymptomatic to se-
vere mandibular and maxillary overgrowth with res-
piratory, speech, vision, and swallowing problems (3). 
Some observations suggest that by the age of twenty, 
lesions spontaneously regress, first in the maxilla and 
then in the mandible (4). Facial appearance may return 
to almost normal by the fourth or fifth decade of life. 
However, some patients request surgical recontouring 
of their residual deformity (5).
Radiologically, the lesions appear as well defined bilat-
eral multilocular radiolucencies, often beginning near 
the mandibular angle and spreading to the mandibular 
ramus and body (5). Additional lesions may involve 
maxillary tuberosities and lesions can spread to all ar-
eas, including the maxillary processes (6). The lesions 
are painless and more or less symmetrical. Bones other 
than the jaws are not usually affected (7,8).
Several family reports from different countries have 
clarified that cherubism is a hereditary bone disease 
(1,9-11) which has no relation to race (7,10-15). Genetic 
research has mapped cherubism to chromosome 4p16.3 
(16).  Furthermore, point mutations in the SH3BP2 gene 
were demonstrated in 12 of 15 families (17). Howe-
ver, other reports have shown that cherubism may oc-
cur without familal history suggesting either de novo 
mutations in SH3BP2 or genetic heterogeneity (14,15). 
Cherubism is a very rare disorder with only an estimat-
ed 300 cases reported in the literature. Because of its 
rarity, it is difficult to determine a disease frequency for 
this disorder (18).
The purpose of this study was to determine whether a 
mutation in the SH3BP2 gene was the molecular ba-
sis of cherubism in a Turkish family. This case report 
describes the history, physical examination, typical 
radiological features and laboratory (molecular and 
histopathological) tests and performs a review of the 
literature.
Study Design
This study began with a 7-year-old (Figure 6: patient 1) 
boy who was referred due to overgrowth of the mandi-
ble. The proband and participating family members (ID 
numbers: 1,2,3,4) were clinically evaluated by extraoral 
and intraoral examination, panoramic X-rays and cone 
beam computed tomography (CBCT).
The study protocol was approved by the Institutional 
Review Boards of the University of Connecticut Health 
Center and Erciyes University Medical School and in-
formed written consent was obtained from the partici-
pating subjects. For the mutation identification, approx-
imately 10 mL peripheral blood was collected from all 
participants and genomic DNA was extracted using a 
Gentra Puregene Blood Kit (Qiagen, Santa Clara, CA).
Results
-Study Cohort
A total of four family members were tested for SH3BP2 
mutations, namely two siblings and their parents. Both 
patients had been clinically diagnosed with cherubism; 
however, the parents were clinically normal. Patient 
1 (IV1) is a seven-year-old boy who showed mild fa-
cial swelling and a delayed permanent first molar in 
the lower jaw. In patient 2 (IV2) who is a five-year-old 
girl, an osseous defect and multiple symmetrical cysts 
in the mandibula and maxilla had been detected. She 
showed more swollen facial characteristics compared to 
her brother. The proband also complained of swelling 
of the right posterior maxillar region. Extraoral exami-
nation showed bilateral non-tender enlargement of the 
lower and upper jaws giving a chubby appearance to 
both cheeks (Fig. 1). Intraoral examination revealed an 
inflammatory mucosa around the maxillary permanent 
first molar tooth in the right maxillary region (Fig. 1) 
and multiple swellings in the posterior maxillary and 
mandibular regions (Fig. 1) which were sessile, hard, 
non-tender and covered by pink mucosa. Blue sclerae 
were also observed. Panoramic radiograph (Fig. 1), and 
the cone beam computed tomography (CBCT) images 
(Fig. 1) showed bilateral, multilocular, expansile-radi-
olucencies with cortical thinning and destruction within 
the ramus, angulus and corpus of both sides of the man-
dible. Similar lesions were also noted in the maxilla. 
A bone biopsy from the mandible was consistent with 
giant cell granuloma (Fig. 1). The members (parents 
and two sisters) of the proband’s family were invited to 
our dental department. His sister (patient IV2), who is a 
five-year-old girl, presented with a painless symmetrical 
progressive swelling of the cheeks. Intraoral evaluation 
of the posterior maxillary and mandibular molar region 
revealed bone expansion, which was firm and hard to 
palpation with intact overlying mucosa. A panoramic 
radiograph (Fig. 2) revealed bilateral multilocular, ex-
pansile radiolucencies of the mandible, particularly in 
the symphysis of the mandible. The lesions spared the 
mandibular condyles but involved the maxillary tuber-
osities. In the panoramic radiograph the developing 
tooth germs for the permanent second premolars were 
not visible. Clinical and radiographic evaluation of oth-
er members of the family (father III3, mother III4, sister 
IV5) was normal (Fig. 2). 
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Fig. 1. Clinical view of the proband (patient IV1) with cherubism 
showing prominent swelling on both sides (a) and intraoral view of 
the patient (b, c). Orthopantomogram showing multiple radiolucen-
cies in mandible and maxilla (d). Axial CBCT images at the level 
of the maxilla (e) and mandible (f) display grossly expansile cystic 
lesions involving both bones with cortical scalloping. Typical histo-
pathology of cherubism. A histological section from the cherubism 
lesion demonstrates the typical finding of multinucleated osteoclast-
like giant cells (arrows) near bone and within soft fibrous stroma. 
Original magnification 200x. (g).
Fig. 2. Panoramic radiographs of proband’s family members. 
Cherubism patient IV2 and clinically and radiographically normal 
little sister (IV5) and parents III3 and III4. Fig. 3. Pedigree of CBM family included in the study. Pedigree show-
ing autosomal-dominant inheritance of CBM. Individuals who were 
tested by Sanger sequencing are indicated by arrows (a). SH3BP2 
mutations in GENOMIC DNA. The electropherograms show 1244 
G>A transversion in SH3BP2 of 2 patients (IV1: proband and IV2: 
middle sister), the unaffected father (III3) and the clinically normal 
but genotypically affected mother (III4) (b).
-Mutation Identification in SH3BP2
Exon 9 of SH3BP2 was amplified from genomic DNA 
by Polymerase Chain Reaction (PCR) using primers 
designed with Primer 3 (http://primer3.sourceforge.
net). Amplifications with primers 5’-CTTGCCGTCCT-
CACACAGAG-3’ and 5’-TTAGGAACTGTGGAGTC-
CTG-3’ were performed in 20 µL reactions containing 
20 ng of genomic DNA, 4 mL 5x PCR buffer, 0.4 mL 10 
mM dNTPs, 1.6 mL 25 mM Mgcl2, 8 µmol of each prim-
er, and 1U Taq DNA polymerase (Promega, Madison, 
WI). Unincorporated primers and dNTPs were removed 
by treating the PCR product with Exosap-IT according 
to the manufacturer’s instructions (Affymetrix, Santa 
Clara, CA). PCR products were sequenced on an ABI 
PRISM 3730 automated sequencer (Genewiz, South 
Plainfield, NJ) and resulting sequences were compared 
to Genebank reference sequence NM_001145856.1.
We found a missense mutation in the proband IV1, the 
affected sibling IV2 and their asymptomatic mother III4 
by Sanger sequencing, which has been previously used 
for cherubism. The mutation was a 1244 G>A transver-
sion which resulted in an amino acid substitution from 
arginine to glutamine (p.Arg415Gln) in exon 9. The 
asymptomatic mother came from a big family in which 
at least six people were affected with cherubism. The 
father had a wild type genotype and no family history 
of cherubism. It appears that the mother is an obligate 
carrier and transmitted the mutation to the two affected 
offspring (Fig. 3).
Discussion
The hallmark of cherubism is the development of sym-
metrical multilocular radiolucent expansile, non-neo-
plastic, self-limiting fibro-osseous lesions in the jaw-
bones (12). Bilateral painless swelling tends to begin 
within a range of 14 months to 12 years of age, usually 
within the first few years of life. In the present study, bi-
lateral swellings were first noticed when children were 
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about three years old. It should be noted that, during 
the late teens, the disease may undergo spontaneous, 
gradual, partial or complete involution and that older 
patients with a mild form of cherubism may have bone 
lesions that have been remodeled with normal mandibu-
lar bone and therefore signs of cherubism may no longer 
be detected by radiographs (7).  In the present study, the 
diagnosis of cherubism was based on patient age, fam-
ily history, clinical examination, radiographic findings, 
and molecular analysis.
The clinical presentation ranges from minor lesions 
without facial deformity to large, deforming, destructive 
lesions with massive involvement of both jaws (6,17). In 
more severe forms of cherubism, the fibro-osseous tis-
sue extends into the inferior and/or lateral orbital walls. 
The skin over the cheeks is stretched and pulls down 
the lower eyelids. Physical displacement of the globe 
and retraction of the eyelid results in exposure of a rim 
of the sclera beneath the iris. In the present study, both 
of the patients affected by cherubism have blue sclera. 
The disease may also invade the retrobulbar spaces of 
the orbits and cause displacement of the optic nerves 
and proptosis (13). Significant ocular disturbances, such 
as lid retraction, proptosis, superior globe displacement 
and diplopia may occur (5). There have been reported 
cases of cherubism with massive enlargement of the jaws 
and backward displacement of the tongue or oblitera-
tion of the nasal airway resulting in airway obstruction 
and obstructive sleep apnea, mouth breathing, snoring, 
chronic nasal infection speech, in addition to mastica-
tion and swallowing problems (3). Some patients with 
severe cherubism report episodic pain (3,13). 
The first radiographic signs of cherubism are usually 
found in the region of the mandibular angle and spread 
to the ascending rami and body of the mandible. The 
radiographic and computed tomography signs of cheru-
bism are as follows: expansile bone remodeling, cortex 
thinning, scalloping and disruption, multilocular radi-
olucencies with a coarse trabecular pattern and soft-tis-
sue density within, dental anomalies, absence of perio-
steal reaction, and sparing of the condyles (19,20). Mag-
netic resonance imaging (MRI) examination is useful in 
elucidating the accurate extent of the cherubic lesions, 
particularly their relationship to the orbits and the optic 
nerves (4). These radiolucent lesions are asymptomatic 
but may affect the development or eruption of the per-
manent molars. The more progressive form of cheru-
bism manifests with multiple symmetrical lesions in the 
mandible or involves the mandible and maxilla with sin-
gular or multiple lesions (21). By 30 years of age, lesions 
are frequently not detectable. In a follow-up study of 18 
patients with cherubism, von Wowern found progressive 
new bone formation in the lesions of patients over 20 
years of age (22). By 41 years of age, the bone structure 
in the affected areas was completely normal. Diagnosis 
in adults with a mild form of cherubism, not appreciated 
in childhood, can be difficult as lytic bone cysts fill in 
with bone and may not be radiographically detectable. 
However, in rare instances actively expanding lesions in 
suspected cherubism may be diagnosed in adults (23). 
Carvalho et al. reported that the cherubism lesions in 
7 of their 8 patients stabilized by the age of 12 years 
and regressed thereafter (5). One more severely affected 
patient showed features of cherubism at the age of 20. 
Radiographic examination at follow-up visits revealed 
filling of the radiolucent lesions with bone as early as 2 
years after stabilization and in most patients when they 
were in their twenties. In the present study, the children 
presented with typical bilateral facial swelling and ra-
diographic evidence of cherubism.
As cherubism is generally a self-limiting condition and 
regresses with age, treatment depends on the clinical 
course of the disease and is indicated only in the cases 
of esthetic or functional problems. The treatment of 
cherubism should be based on the known natural course 
of the disease and the clinical behavior of the individ-
ual case. Most of the cases require no treatment. Most 
dental surgeons prefer to wait until the end of puberty 
before performing a surgery (24). In the present study, 
no treatment option was suggested, the parents were in-
formed about cherubism and the children scheduled for 
a follow-up appointment. During the growth phase of 
the lesions, annual clinical and radiographic examina-
tion with a panoramic or other appropriate radiograph 
is recommended. Follow-up every 2 to 5 years is advis-
able after the disease becomes quiescent. The impact 
of cherubism lesions on the development and eruption 
of the primary and permanent dentition varies depend-
ing on the time of onset and severity of the expansile 
lesions. Widening of the alveolar ridges is common. 
The arrangement of primary teeth can be disturbed (11). 
Disruption of the secondary dentition can include ab-
sent teeth (mostly molars), rudimentary development 
of molars, abnormally shaped teeth, partially resorbed 
roots or delayed and ectopically erupting teeth (11). 
Tooth extraction may be needed, especially if the teeth 
are “free-floating” in cherubism lesions (10) or if they 
become ectopically impacted (22). In more severe in-
stances, children may require prostheses that need to be 
adjusted as the child grows or the swelling within the 
oral cavity changes. A dental prosthesis may improve 
the ability to chew and increase the self-esteem of the 
child. Orthodontic treatment is usually required after 
growth is completed and when cherubism is regressing 
(18). Surgical intervention is often necessary for severe 
functional disturbances (24). Expansion of fibrous le-
sions in severe cases may regress well after adolescence 
(15). In other instances actively expanding lesions in 
suspected cherubism may still be diagnosed in adults. 
Patients with aggressive, rapidly progressing cherubism 
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should be evaluated by a craniofacial team consisting of 
a surgeon (oral and maxillofacial surgeon, plastic sur-
geon, otolaryngologist), geneticist/genetic counselor, 
ophthalmologist, dentist/orthodontist and child psycho-
logist/ social worker and nurse (18). Papadaki et al. (18) 
reported that mild forms of cherubism without facial 
dysmorphology, dental or ocular involvement may not 
require treatment as cherubism is expected to regress 
spontaneously after puberty. Management in these cas-
es consists of longitudinal observation. Von Wowern 
reported 18 patients with cherubism who underwent bi-
opsy with or without autotransplantation of ectopically 
erupted teeth. Surgical treatment did not provoke pro-
gression of the lesions in any of these cases (22), which 
is consistent with other reports (19). Raposo-Amaral et 
al. (20) reported on extensive resection in 8 children 
aged 6 to 15 years old with severe cherubism. Surgical 
resection during the proliferating phase of the disorder 
was performed in 2 stages to prevent excessive blood 
loss. The maxilla and orbits were contour-resected first 
and the mandible 6 months later through intraoral and 
extraoral incisions. The patients were followed-up for 2 
to 18 years and no recurrence was found in any of them. 
Both patients and authors were satisfied with the out-
come and the authors suggest that thorough removal of 
affected tissue appears to arrest the proliferation of any 
remaining tumor tissue (18). In Etoz et al’s case report, 
systemic calcitonin therapy was advocated, and favora-
ble results were achieved (19). 
Radiotherapy is contraindicated because of fear of retar-
dation of jaw growth, radio osteonecrosis and chances 
of malignant degeneration (25).
The authors believe that further phenotype-genotype 
association studies in individuals with cherubism will 
help in establishing the basis for phenotypic variabi-
lity and provide important clues to its pathogenesis. 
The present study emphasizes the significance of 
additional clinical and molecular examination even 
when only a single case of cherubism is identified 
within a family.
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